The Valley Desk

NCT02988817 · Interventional trial

Enapotamab Vedotin (HuMax-AXL-ADC) Safety Study in Patients With Solid Tumors

Overall registry status Completed

Phase 1 · Phase 2

Conditions Cervical Cancer, Endometrial Cancer, Melanoma, Non Small Cell Lung Cancer (NSCLC), Ovarian Cancer, Sarcoma, Solid Tumors, Thyroid Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov